Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries
- PMID: 15579758
- DOI: 10.1210/jc.2004-0571
Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries
Abstract
Over a period of almost 10 yr, we carried out a prospective study of the neuropsychological development of the offspring of 16 women from a moderately iodine-deficient area (area A) and of 11 control women from a marginally iodine-sufficient area (area B) whose thyroid function had been monitored during early gestation. Attention deficit and hyperactivity disorder (ADHD) was diagnosed in 11 of 16 area A children (68.7%) but in none from area B. Total intelligence quotient score was lower in area A than in area B children (92.1 +/- 7.8 vs. 110 +/- 10) and in ADHD children when compared with both non-ADHD children from the same area and control children (88.0 +/- 6.9 vs. 99.0 +/- 2.0 and 110 +/- 10, respectively). Seven of 11 ADHD children (63.6%) were born to the seven of eight area A mothers who became hypothyroxinemic at early gestation, whereas only one of five non-ADHD children was born to a woman who was hypothyroxinemic at 20 wk of gestation. So far, a similar prevalence of ADHD has been reported only in children with generalized resistance to thyroid hormones. This might suggest a common ADHD pathogenetic mechanism consisting either of reduced sensitivity of the nuclear receptors to thyroid hormone (generalized resistance to thyroid hormones) or reduced availability of intracellular T3 for nuclear receptor binding. The latter would be the ultimate consequence of maternal hypothyroxinemia (due to iodine deficiency), resulting in a critical reduction of the source of the intracellular T3 available to the developing fetal brain.
Similar articles
-
Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation.Thyroid. 2009 May;19(5):511-9. doi: 10.1089/thy.2008.0341. Thyroid. 2009. PMID: 19348584
-
Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children.JAMA Pediatr. 2015 Sep;169(9):838-45. doi: 10.1001/jamapediatrics.2015.0498. JAMA Pediatr. 2015. PMID: 26146876
-
Feto-maternal repercussions of iodine deficiency during pregnancy. An update.Ann Endocrinol (Paris). 2003 Feb;64(1):37-44. Ann Endocrinol (Paris). 2003. PMID: 12707632 Review.
-
Environmental risk factors by gender associated with attention-deficit/hyperactivity disorder.Pediatrics. 2014 Jan;133(1):e14-22. doi: 10.1542/peds.2013-1434. Epub 2013 Dec 2. Pediatrics. 2014. PMID: 24298003
-
Clinical and biological consequences of iodine deficiency during pregnancy.Endocr Dev. 2007;10:62-85. doi: 10.1159/000106820. Endocr Dev. 2007. PMID: 17684390 Review.
Cited by
-
Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches.Environ Health Perspect. 2019 Sep;127(9):95001. doi: 10.1289/EHP5297. Epub 2019 Sep 5. Environ Health Perspect. 2019. PMID: 31487205 Free PMC article.
-
Elemental Metabolomics and Pregnancy Outcomes.Nutrients. 2019 Jan 2;11(1):73. doi: 10.3390/nu11010073. Nutrients. 2019. PMID: 30609706 Free PMC article. Review.
-
Seasons but not ethnicity influence urinary iodine concentrations in Belgian adults.Eur J Nutr. 2011 Jun;50(4):285-90. doi: 10.1007/s00394-010-0137-4. Epub 2010 Oct 20. Eur J Nutr. 2011. PMID: 20960000
-
Thyroid Hormone Signalling: From the Dawn of Life to the Bedside.J Mol Evol. 2020 Jan;88(1):88-103. doi: 10.1007/s00239-019-09908-1. Epub 2019 Aug 27. J Mol Evol. 2020. PMID: 31451837 Review.
-
Iodine-fortified toddler milk improves dietary iodine intakes and iodine status in toddlers: a randomised controlled trial.Eur J Nutr. 2020 Apr;59(3):909-919. doi: 10.1007/s00394-019-01950-5. Epub 2019 Mar 30. Eur J Nutr. 2020. PMID: 30929067 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical